Tashiro M, et al. - Researchers hypothesized that corticosteroid therapy could reduce mortality and length of stay (LOS) in patients with Mycoplasma pneumoniae pneumonia. In this study, it was demonstrated that low-dose or high-dose corticosteroids when given as adjunctive therapy in patients with Mycoplasma pneumoniae pneumonia, may not afford benefit.